NasdaqGS - Nasdaq Real Time Price USD
Denali Therapeutics Inc. (DNLI)
14.55
-0.38
(-2.51%)
At close: June 13 at 4:00:01 PM EDT
14.55
0.00
(0.00%)
After hours: June 13 at 4:36:07 PM EDT
Insider Purchases Last 6 Months
Shares | Transactions | |
---|---|---|
Purchases | 232,637 | 12 |
Sales | 103,659 | 6 |
Net Shares Purchased (Sold) | 128,978 | 18 |
Total Insider Shares Held | 14.48M | -- |
% Net Shares Purchased (Sold) | 0.90% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
Shares | |
---|---|
Net Shares Purchased (Sold) | -- |
% Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
Insider | Transaction | Type | Value | Date |
---|---|---|---|---|
FLATLEY JAY T Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 3, 2025 |
TESSIER LAVIGNE MARC T Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 3, 2025 |
KLEIN PETER S Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 3, 2025 |
SCHENKEIN DAVID P Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 3, 2025 |
KROGNES STEVE E Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 3, 2025 |
COOK JENNIFER E Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 3, 2025 |
BAKER BROS ADVISORS, L.P. Director | Stock Award(Grant) at price 0.00 per share. | Indirect | 0 | Jun 3, 2025 |
THORNBERRY NANCY A. Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 3, 2025 |
HO CAROLE Officer | Sale at price 20.22 - 20.81 per share. | Direct | 308,291 | Jan 7, 2025 |
KROGNES STEVE E Director | Sale at price 20.81 per share. | Direct | 69,485 | Jan 7, 2025 |
SCHUTH ALEXANDER O Chief Operating Officer | Sale at price 20.22 - 20.81 per share. | Direct | 308,291 | Jan 7, 2025 |
WATTS RYAN J Chief Executive Officer | Sale at price 20.22 - 20.81 per share. | Direct | 750,955 | Jan 7, 2025 |
SCHUTH ALEXANDER O Chief Operating Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 3, 2025 |
HO CAROLE Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 3, 2025 |
WATTS RYAN J Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 3, 2025 |
SATO VICKI LEE Director | Sale at price 20.91 per share. | Direct | 64,403 | Jan 2, 2025 |
KROGNES STEVE E Director | Sale at price 20.25 per share. | Direct | 607,500 | Dec 31, 2024 |
SCHUTH ALEXANDER O Chief Operating Officer | Conversion of Exercise of derivative security at price 5.28 per share. | Direct | 35,418 | Dec 27, 2024 |
HO CAROLE Officer | Conversion of Exercise of derivative security at price 0.68 per share. | Direct | 12,135 | Nov 25, 2024 |
SCHUTH ALEXANDER O Chief Operating Officer | Conversion of Exercise of derivative security at price 0.68 per share. | Direct | 13,951 | Nov 22, 2024 |
SCHENKEIN DAVID P Director | Sale at price 32.09 - 32.87 per share. | Direct | 1,932,665 | Nov 11, 2024 |
SCHENKEIN DAVID P Director | Conversion of Exercise of derivative security at price 18.00 per share. | Direct | 848,970 | Nov 11, 2024 |
SATO VICKI LEE Director | Sale at price 30.00 per share. | Direct | 30,600 | Nov 7, 2024 |
SCHUTH ALEXANDER O Officer | Sale at price 29.68 - 31.29 per share. | Direct | 465,286 | Nov 7, 2024 |
SCHUTH ALEXANDER O Officer | Conversion of Exercise of derivative security at price 5.28 per share. | Direct | 82,146 | Nov 7, 2024 |
SATO VICKI LEE Director | Sale at price 27.07 per share. | Direct | 83,376 | Nov 1, 2024 |
WATTS RYAN J Chief Executive Officer | Sale at price 27.69 per share. | Direct | 1,107,600 | Oct 18, 2024 |
WATTS RYAN J Chief Executive Officer | Conversion of Exercise of derivative security at price 0.68 per share. | Direct | 27,200 | Oct 18, 2024 |
KROGNES STEVE E Director | Sale at price 29.03 per share. | Direct | 870,900 | Sep 30, 2024 |
SATO VICKI LEE Director | Sale at price 30.00 per share. | Direct | 30,600 | Sep 13, 2024 |
SATO VICKI LEE Director | Sale at price 24.99 - 25.37 per share. | Direct | 77,007 | Sep 3, 2024 |
HO CAROLE Officer | Sale at price 23.79 - 24.96 per share. | Direct | 549,928 | Aug 21, 2024 |
SCHUTH ALEXANDER O Officer | Sale at price 23.54 - 24.78 per share. | Direct | 200,401 | Aug 21, 2024 |
KROGNES STEVE E Director | Sale at price 23.79 per share. | Direct | 41,085 | Aug 20, 2024 |
WATTS RYAN J Chief Executive Officer | Sale at price 23.79 per share. | Direct | 53,765 | Aug 20, 2024 |
HO CAROLE Officer | Sale at price 22.89 per share. | Direct | 53,494 | Aug 13, 2024 |
SCHUTH ALEXANDER O Chief Operating Officer | Sale at price 22.89 per share. | Direct | 52,006 | Aug 13, 2024 |
SATO VICKI LEE Director | Sale at price 22.12 - 22.86 per share. | Direct | 68,204 | Jul 1, 2024 |
KROGNES STEVE E Director | Sale at price 21.79 - 22.80 per share. | Direct | 678,660 | Jul 1, 2024 |
COOK JENNIFER E Director | Sale at price 21.73 per share. | Direct | 31,682 | Jun 6, 2024 |
FLATLEY JAY T Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 31, 2024 |
SATO VICKI LEE Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 31, 2024 |
TESSIER LAVIGNE MARC T Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 31, 2024 |
KLEIN PETER S Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 31, 2024 |
SCHENKEIN DAVID P Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 31, 2024 |
KROGNES STEVE E Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 31, 2024 |
COOK JENNIFER E Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 31, 2024 |
HARRIS ERIK Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 31, 2024 |
THORNBERRY NANCY A. Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 31, 2024 |
SATO VICKI LEE Director | Sale at price 20.39 per share. | Direct | 34,133 | May 15, 2024 |
Related Tickers
ALEC Alector, Inc.
1.5400
-4.94%
MIRM Mirum Pharmaceuticals, Inc.
49.63
+1.24%
RARE Ultragenyx Pharmaceutical Inc.
37.49
-4.58%
APLS Apellis Pharmaceuticals, Inc.
18.83
-2.23%
IMVT Immunovant, Inc.
15.66
-1.76%
BPMC Blueprint Medicines Corporation
127.96
-0.19%
CRNX Crinetics Pharmaceuticals, Inc.
31.77
-1.24%
PCVX Vaxcyte, Inc.
34.56
+0.29%
SRRK Scholar Rock Holding Corporation
32.45
-2.61%
STOK Stoke Therapeutics, Inc.
11.53
-2.45%